Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region

Julia Close, MD : Research

Cancer Specialist (Oncologist), Hematologist (Blood Disease Specialist)

Photo of Julia Close

Research at a glance

Top areas of exploration

  • Medical Oncology , 7 publications
  • Hematology , 4 publications
  • Antineoplastic Agents , 3 publications
  • Neoplasms , 2 publications

Research activity

26 publications

228 citations

Why is this important?

Focus

Dr. Close's research interest is in optimizing education for learners at all levels, with a focus on Graduate Medical Education, specifically fellows. She has developed both local and national curriculum. Local efforts include incorporating team based learning and virtual patients into the fellowship oncology curriculum. At a national level, she was one of 3 editors representing the American Society of Clinical Oncology (ASCO) in the development and improvement of a collaborative curriculum between the European Society for Medical Society (ESMO) and ASCO, to be used for oncology programs outside the United States. She is also interested in providing education to improve the physician and patient interaction at the end of life, and is currently pursuing research into this area. Finally, she is interested in preventing burn-out in physicians-in-training, and has recently worked with colleagues to expand the resiliency curriculum within the fellowship program.

My publications

26 publications

2024

A point-of-care pilot randomized intervention to connect patients with cancer-induced financial toxicity to telehealth financial counseling.

Cancer causes & control : CCC

PubMed Publisher's site

2023

Are evaluations in simulated medical encounters reliable among rater types? A comparison between standardized patient and outside observer ratings of OSCEs.

PEC innovation

PubMed Publisher's site

2023

Frequency, barriers, outcomes, and consequences of reporting sexual harassment in clinical oncology.

JNCI cancer spectrum

PubMed Publisher's site

2023

Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

PubMed Publisher's site

2022

A Multicentered Academic Medical Center Experience of a Simulated Root Cause Analysis (RCA) for Hematology/Oncology Fellows.

Journal of cancer education : the official journal of the American Association for Cancer Education

PubMed Publisher's site